156 related articles for article (PubMed ID: 10845700)
41. Retroviral proteases and their roles in virion maturation.
Konvalinka J; Kräusslich HG; Müller B
Virology; 2015 May; 479-480():403-17. PubMed ID: 25816761
[TBL] [Abstract][Full Text] [Related]
42. Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase.
Zahuczky G; Boross P; Bagossi P; Emri G; Copeland TD; Oroszlan S; Louis JM; Tözsér J
Biochim Biophys Acta; 2000 Mar; 1478(1):1-8. PubMed ID: 10719169
[TBL] [Abstract][Full Text] [Related]
43. Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein.
Shoeman RL; Höner B; Stoller TJ; Kesselmeier C; Miedel MC; Traub P; Graves MC
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6336-40. PubMed ID: 2201025
[TBL] [Abstract][Full Text] [Related]
44. A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein.
Brody BA; Rhee SS; Sommerfelt MA; Hunter E
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3443-7. PubMed ID: 1565636
[TBL] [Abstract][Full Text] [Related]
45. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
Lin YC; Brik A; de Parseval A; Tam K; Torbett BE; Wong CH; Elder JH
J Virol; 2006 Aug; 80(16):7832-43. PubMed ID: 16873240
[TBL] [Abstract][Full Text] [Related]
46. Bovine leukemia virus: purification and characterization of the aspartic protease.
Menard A; Mamoun RZ; Geoffre S; Castroviejo M; Raymond S; Precigoux G; Hospital M; Guillemain B
Virology; 1993 Apr; 193(2):680-9. PubMed ID: 8384751
[TBL] [Abstract][Full Text] [Related]
47. Mouse homologue of skin-specific retroviral-like aspartic protease involved in wrinkle formation.
Matsui T; Kinoshita-Ida Y; Hayashi-Kisumi F; Hata M; Matsubara K; Chiba M; Katahira-Tayama S; Morita K; Miyachi Y; Tsukita S
J Biol Chem; 2006 Sep; 281(37):27512-25. PubMed ID: 16837463
[TBL] [Abstract][Full Text] [Related]
48. Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase.
Hrusková-Heidingsfeldová O; Bláha I; Urban J; Strop P; Pichová I
Leukemia; 1997 Apr; 11 Suppl 3():45-6. PubMed ID: 9209292
[TBL] [Abstract][Full Text] [Related]
49. Breaking the shackles of the genetic code: engineering retroviral proteases through total chemical synthesis.
Kent SB; Baca M; Elder J; Miller M; Milton R; Milton S; Rao JK; Schnölzer M
Adv Exp Med Biol; 1995; 362():425-38. PubMed ID: 8540353
[No Abstract] [Full Text] [Related]
50. Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and EIAV.
Kervinen J; Lubkowski J; Zdanov A; Bhatt D; Dunn BM; Hui KY; Powell DJ; Kay J; Wlodawer A; Gustchina A
Protein Sci; 1998 Nov; 7(11):2314-23. PubMed ID: 9827997
[TBL] [Abstract][Full Text] [Related]
51. Analysis of cross reactivity of retrovirus proteases using a vaccinia virus-T7 RNA polymerase-based expression system.
Luukkonen BG; Tan W; Fenyö EM; Schwartz S
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2169-80. PubMed ID: 7561754
[TBL] [Abstract][Full Text] [Related]
52. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.
Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD
Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829
[TBL] [Abstract][Full Text] [Related]
53. High-resolution structure of a retroviral protease folded as a monomer.
Gilski M; Kazmierczyk M; Krzywda S; Zábranská H; Cooper S; Popović Z; Khatib F; DiMaio F; Thompson J; Baker D; Pichová I; Jaskolski M
Acta Crystallogr D Biol Crystallogr; 2011 Nov; 67(Pt 11):907-14. PubMed ID: 22101816
[TBL] [Abstract][Full Text] [Related]
54. Intermediate filament assembly and stability in vitro: effect and implications of the removal of head and tail domains of vimentin by the human immunodeficiency virus type 1 protease.
Shoeman RL; Mothes E; Kesselmeier C; Traub P
Cell Biol Int Rep; 1990 Jul; 14(7):583-94. PubMed ID: 2203542
[TBL] [Abstract][Full Text] [Related]
55. [Conserved interactions of the active carboxyls in pepsin-like enzymes and retroviral proteases].
Andreeva NS; Popov ME
Mol Biol (Mosk); 2002; 36(5):939-44. PubMed ID: 12391858
[TBL] [Abstract][Full Text] [Related]
56. Purification and characterization of a vimentin-specific protease in mouse myeloid leukemia cells. Regulation during differentiation and identity with cathepsin G.
Nakamura N; Tsuru A; Hirayoshi K; Nagata K
Eur J Biochem; 1992 May; 205(3):947-54. PubMed ID: 1577012
[TBL] [Abstract][Full Text] [Related]
57. Synthetic approaches to continuous assays of retroviral proteases.
Krafft GA; Wang GT
Methods Enzymol; 1994; 241():70-86. PubMed ID: 7854193
[TBL] [Abstract][Full Text] [Related]
58. Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding.
Daenke S; Schramm HJ; Bangham CR
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2233-9. PubMed ID: 8077922
[TBL] [Abstract][Full Text] [Related]
59. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer.
Matayoshi ED; Wang GT; Krafft GA; Erickson J
Science; 1990 Feb; 247(4945):954-8. PubMed ID: 2106161
[TBL] [Abstract][Full Text] [Related]
60. Template-specific requirements for DNA synthesis by the Mason-Pfizer monkey virus DNA polymerase: unique aspects.
Marcus SL; Sarkar NH; Modak MJ
Biochim Biophys Acta; 1978 Jul; 519(2):317-30. PubMed ID: 78724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
